Drug Shortage Report for LOVENOX HP

Last updated on 2023-05-17 History
Report ID 185718
Drug Identification Number 02242692
Brand name LOVENOX HP
Common or Proper name LOVENOX HP 120 MG / 0.8 ML
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) ENOXAPARIN SODIUM
Strength(s) 120MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-03-20
Actual start date 2023-04-13
Estimated end date 2023-05-23
Actual end date 2023-05-16
Shortage status Resolved
Updated date 2023-05-17
Company comments Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2023-05-17 French Compare
v15 2023-05-17 English Compare
v14 2023-05-15 French Compare
v13 2023-05-15 English Compare
v12 2023-04-21 French Compare
v11 2023-04-21 English Compare
v10 2023-04-21 English Compare
v9 2023-04-21 English Compare
v8 2023-04-14 English Compare
v7 2023-04-13 French Compare
v6 2023-04-13 English Compare
v5 2023-03-21 English Compare
v4 2023-02-28 French Compare
v3 2023-02-28 English Compare
v2 2023-02-28 French Compare
v1 2023-02-28 English Compare

Showing 1 to 16 of 16